Improved Long-Term Outcome With Chemoradiotherapy Strategies in Esophageal Cancer Stephen G. Swisher, MD, Wayne Hofstetter, MD, Ritsuko Komaki, MD, Arlene.

Slides:

Advertisements

Similar presentations

Differential Response to Preoperative Chemoradiation and Surgery in Esophageal Adenocarcinomas Based on Presence of Barrett's Esophagus and Symptomatic.

Advertisements

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E

A Prognostic Scoring Model for the Utility of Induction Chemotherapy Prior to Neoadjuvant Chemoradiotherapy in Esophageal Cancer Mian Xi, MD, Zhongxing.

Photodynamic Laser Therapy for Lesions in the Airway

The evolution of treatment outcomes for resected stage IIIA non–small cell lung cancer over 16 years at a single institution Linda W. Martin, MD, Arlene.

Preoperative Chemo-Radiation-Induced Ulceration in Patients with Esophageal Cancer: A Confounding Factor in Tumor Response Assessment in Integrated Computed.

Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

Results of Neoadjuvant Chemoradiotherapy With Docetaxel and 5-Fluorouracil Followed by Esophagectomy to Treat Locally Advanced Esophageal Cancer Yoichi.

Outcomes of Reintervention on the Autograft After Ross Procedure

Utility of PET, CT, and EUS to Identify Pathologic Responders in Esophageal Cancer Stephen G. Swisher, MD, Mary Maish, MD, Jeremy J. Erasmus, MD, Arlene.

Neoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinoma: Significance of microscopically positive circumferential radial margins

Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis

Zhiqiang Xue, MD, Fengying Wu, MD, Karlyn E

Laura Harvey, MD, Christopher Holley, MD, Samit S

Final Results of NRG Oncology RTOG 0246: An Organ-Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiation

Puja Gaur, MD, Wayne L. Hofstetter, MD, B

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Adjuvant Chemotherapy with 5-Fluorouracil and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma Jeeyun Lee, MD, Kyoung-Eun.

Influence of Preoperative Radiation Field on Postoperative Leak Rates in Esophageal Cancer Patients after Trimodality Therapy Aditya Juloori, BS, Susan.

Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population Edmund S. Kassis, MD, Ara A. Vaporciyan,

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy Apar Pataer, MD, PhD, Neda Kalhor,

Tina Cascone, MD, PhD, Kathryn A. Gold, MD, Stephen G

Non-Small Cell Lung Cancer Resection in Lymphoma Patients

Castigliano M. Bhamidipati, DO, MS, George J

Endoscopic Ultrasound Estimates for Tumor Depth at the Gastroesophageal Junction Are Inaccurate: Implications for the Liberal Use of Endoscopic Resection

Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port,

Operative Results and Outcomes in Children With Shone's Anomaly

Complex Esophageal Reconstruction Procedures Have Acceptable Outcomes Compared With Routine Esophagectomy Jessica M. Moore, BS, Craig M. Hooker, PhD,

Adding Radiotherapy to Adjuvant Chemotherapy Does Not Improve Survival of Patients With N2 Lung Cancer Justin A. Drake, MD, David C. Portnoy, MD, Kurt.

David C. Rice, MB, BCh, Matthew A

Chris Dickhoff, MD, Max Dahele, MD, PhD, Sayed M

Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D

Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases Haifeng Wang, MM, Hongsheng Lin, MM, Gening.

Anthony J. Ascioti, MD, Wayne L. Hofstetter, MD, Michael J

Resection of Intraabdominal Tumors With Cavoatrial Extension Using Deep Hypothermic Circulatory Arrest Christopher Lau, MD, Padraic O’Malley, MD, Mario.

Total Arterial Revascularization: A Superior Strategy for Diabetic Patients Who Require Coronary Surgery James Tatoulis, MD, FRACS, Rochelle Wynne, PhD,

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Shanda H. Blackmon, MD, Arlene M

Proposed Modification of Nodal Status in AJCC Esophageal Cancer Staging System Wayne Hofstetter, MD, Arlene M. Correa, PhD, Neby Bekele, PhD, Jaffer A.

The Role of Consolidation Therapy for Stage III Non-Small Cell Lung Cancer With Persistent N2 Disease After Induction Chemotherapy Arya Amini, BA, Arlene.

Dhakshina Moorthy Ganeshan, MD, Arlene M

Outcomes After Extrapleural Pneumonectomy and Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma David C. Rice, MB, BCh, Craig.

Brendon M. Stiles, MD, Mohamed K. Kamel, MD, Sebron W

Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D

Predictors of Nodal Metastases for Clinical T2N0 Esophageal Adenocarcinoma Arianna Barbetta, MD, Francisco Schlottmann, MD, Tamar Nobel, MD, David B.

Characteristics of Malignant Pleural Mesothelioma in Women

Jonathan D. Spicer, MD, PhD, Jitesh B. Shewale, BDS, PhD, David B

Preoperative Chemotherapy Does Not Increase Complications After Nonsmall Cell Lung Cancer Resection Emilie Perrot, MD, Benoit Guibert, MD, Pierre Mulsant,

A Prognostic Scoring Model for the Utility of Induction Chemotherapy Prior to Neoadjuvant Chemoradiotherapy in Esophageal Cancer Mian Xi, MD, Zhongxing.

Association between Systemic Chemotherapy before Chemoradiation and Increased Risk of Treatment-Related Pneumonitis in Esophageal Cancer Patients Treated.

David C. Rice, MB, BCh, Jeremy J. Erasmus, MD, Craig W

Attila Dubecz, MD, Thomas J. Watson, MD, Daniel P

Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer Stephen G. Swisher, MDa, Linda DeFord, MSb, Kelly.

Visceral Pleural Invasion Is Not Predictive of Survival in Patients With Lung Cancer and Smaller Tumor Size Elizabeth David, MD, Peter F. Thall, PhD,

Predictors of Recurrent Pulmonary Metastases and Survival After Pulmonary Metastasectomy for Colorectal Cancer Shanda H. Blackmon, MD, MPH, Elizabeth.

Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer Pamela Samson, MD, MPHS, Varun.

Mara B. Antonoff, MD, Wayne L. Hofstetter, MD, Arlene M

Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer? Anna Lee, MD, MPH, Andrew T.

Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population Christian McNeely, MD, Stephen.

Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer Pamela Samson, MD, Aalok Patel,

Neoadjuvant Chemoradiation Therapy Is Beneficial for Clinical Stage T2 N0 Esophageal Cancer Patients Due to Inaccurate Preoperative Staging Jennifer.

Left-Sided Reoperations After Arterial Switch Operation: A European Multicenter Study Vladimiro L. Vida, MD, PhD, Lorenza Zanotto, MD, Lucia Zanotto,

Steve K. Singh, MD, Gilbert H. L. Tang, MD, Manjula D

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Jenifer L. Marks, MD, Wayne Hofstetter, MD, Arlene M

Induction Chemoradiation Is Not Superior to Induction Chemotherapy Alone in Stage IIIA Lung Cancer Asad A. Shah, MD, Mark F. Berry, MD, Ching Tzao, MD,

The risk of second primary tumors after resection of stage I nonsmall cell lung cancer David Rice, MB, BCh, Hyung-Woo Kim, MS, Anita Sabichi, MD, Scott.

Presentation transcript:

Improved Long-Term Outcome With Chemoradiotherapy Strategies in Esophageal Cancer Stephen G. Swisher, MD, Wayne Hofstetter, MD, Ritsuko Komaki, MD, Arlene M. Correa, PhD, Jeremy Erasmus, MD, Jeffrey H. Lee, MD, Zhongxing Liao, MD, Dipen Maru, MD, Reza Mehran, MD, Shital Patel, MD, David C. Rice, MD, Jack A. Roth, MD, Ara A. Vaporciyan, MD, Garrett L. Walsh, MD, Jaffer A. Ajani, MD The Annals of Thoracic Surgery Volume 90, Issue 3, Pages 892-899 (September 2010) DOI: 10.1016/j.athoracsur.2010.04.061 Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Kaplan-Meier survival graph demonstrating improved overall survival with 95% confidence intervals of group B preoperative chemoradiotherapy (Pre-op C/RT) patients versus group A preoperative chemotherapy (Pre-op C) patients in sequential phase II/III trials (p = 0.046). The Annals of Thoracic Surgery 2010 90, 892-899DOI: (10.1016/j.athoracsur.2010.04.061) Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Kaplan-Meier disease-free survival graph demonstrating improved disease-free survival with 95% confidence intervals of group B preoperative chemoradiotherapy (Pre-op C/RT) patients versus group A preoperative chemotherapy (Pre-op C) patients in sequential phase II/III trials (p = 0.015). The Annals of Thoracic Surgery 2010 90, 892-899DOI: (10.1016/j.athoracsur.2010.04.061) Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions